Disclosing conflicts of interest in clinical research: Views of institutional review boards, conflict of interest committees, and investigators

Journal of Law, Medicine and Ethics

Volumn 34, Issue 3, 2006, Pages 581-591

  Weinfurt, Kevin P ^a,b   Friedman, Joëlle Y ^c   Dinan, Michaela A ^c   Allsbrook, Jennifer S ^c   Hall, Mark A ^d   Dhillon, Jatinder K ^c   Sugarman, Jeremy ^e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Center for Clinical and Genetic Economics   (United States)

^d WAKE FOREST UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COMMUNICATION DISORDER; CONFERENCE PAPER; CONFLICT OF INTEREST; DECISION MAKING; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; INTERVIEW; LEGAL LIABILITY; MEDICAL RESEARCH; MULTICENTER STUDY; POLICY; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; RESEARCH SUBJECT; TRUST; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; BIOMEDICAL RESEARCH; COMMUNICATION BARRIERS; CONFLICT OF INTEREST; DECISION MAKING; DISCLOSURE; ETHICS COMMITTEES, RESEARCH; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; INTERVIEWS; INTERVIEWS AS TOPIC; LIABILITY, LEGAL; ORGANIZATIONAL POLICY; RESEARCH SUBJECTS; RESEARCH SUPPORT; RESEARCH SUPPORT AS TOPIC; TRUST; UNITED STATES;

EID: 33749416589     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2006.00072.x     Document Type: Conference Paper

References (16)

1. M. Angell, "Is Academic Medicine for Sale?" New England Journal of Medicine 342 (2000): 1516-1518;
2. T. Bodenheimer, "Uneasy Alliance - Clinical Investigators and the Pharmaceutical Industry," New England Journal of Medicine, 342 (2000): 1539-1544;
3. S. G. Korenman, "Conflicts of Interest and Commercialization of Research," Academic Medicine 68, no. 9 (suppl) (1993): S18-S22;
4. D. Shalala, "Protecting Research Subjects - What Must Be Done, " New England Journal of Medicine 343 (2000): 808-810.
5. Department of Health and Human Services, "Financial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection," Federal Register 69 (2004): 26393-26397.
6. K. P. Weinfurt, M. A. Dinan, J. S. Allsbrook, et al., "Policies of Academic Medical Centers for Disclosing Conflicts of Interest to Potential Research Participants," "Academic Medicine 81 (2006): 113-118.
7. 45 C.F.R. § 46 (2005); 21 C.F.R. § 50 (2005); 21 C.F.R. § 56 (2005).
8. R. A. Krueger, Focus Groups, 2nd edition (Thousand Oaks, CA: Sage Publications, 1994).
9. R. R. Faden and T. L. Beauchamp, A History and Theory of Informed Consent (New York: Oxford University Press, 1986).
10. Id.
11. See Weinfurt, et al., supra note 3.
12. D. M. Cain, G. Loewenstein, and D. A. Moore, "The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest," Journal of Legal Studies 34 (2005): 1-25.
13. E. A. Boyd, M. K. Cho, and L. A. Bero, "Financial Conflict-of-interest Policies in Clinical Research: Issues for Clinical Investigators," Academic Medicine 78 (2003): 769-774.
14. Id.;
15. D. B. Resnik, "Disclosing Conflicts of Interest to Research Subjects: An Ethical and Legal Analysis," Accountability in Research, 11 (2004): 141-159;
16. C. E. Schneider, "Reaching Disclosure," Hastings Center Report 35 (2005): 12-13.